Clinical Trials- Cancer Control

 

 DISEASE STIE TITLE  PHASE  CONTACT   LOCATION
 Cancer Control Pilot Placebo-controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute
Pain Syndrome  (RC11C3) 
 

Natasha Wilson, nwilson@mvcc.cc

402-991-8070 x203

----------------------------------

Nebraska Cancer Research Center – Kelly Madcharo – kmadcharo@lmep.com

Missouri Valley Cancer Consortium, Omaha, NE;  Nebraska Cancer Research Center, Lincoln, NE

 Cancer Control  A Prospective Observational Multi-Center Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting Zoledronic Acid Treatment.  (S0702)  

 Natasha Wilson, nwilson@mvcc.cc

 402-991-8070 x203

 Missouri Valley Cancer Consortium, Omaha, NE
 Cancer Control  Change in Mammographic Density with Metformin Use: A Companion Study to NCIC Study MA.32 (A211201)  

 Natasha Wilson, nwilson@mvcc.cc

 402-991-8070 x203

 Missouri Valley Cancer Consortium, Omaha, NE
 Cancer Control  A Phase III, Randomized, Study of Sulfasalazine versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy (NCCTG-N08C9)  III  

Nebraska Cancer Research Center – Kelly Madcharo – kmadcharo@lmep.com

 Nebraska Cancer Research Center, Lincoln, NE

Nebraska Oncology Society
c/o Nebraska Medical Association
Sarah Dunbar
Executive Director
233 South 13th Street Suite 1200
Lincoln, NE 68508
sarahd@nebmed.org (email)
402-474-4472 (phone)
402-474-2198 (fax)

Powered by Wild Apricot Membership Software